27.05.2016 18:17:14
|
Relypsa Pulls Back Off Best Levels But Holding On To Strong Gain
(RTTNews) - Shares of Relypsa (RLYP) are seeing notable strength in afternoon trading on Friday, with the biopharmaceutical company up by 12.3 percent. Earlier in the session, Relypsa reached its best intraday level in a month.
The strong gain by Relypsa comes after the FDA rejected AstraZeneca's (AZN) competing potassium-lowering drug. Relypsa received FDA approval for its own potassium-lowering drug Veltassa last October.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Relypsa Incmehr Nachrichten
Keine Nachrichten verfügbar. |